Wellbutrin and Neuroleptic malignant syndrome - from FDA reports


Summary

Neuroleptic malignant syndrome is found among people who take Wellbutrin, especially for people who are female, 50-59 old , have been taking the drug for < 1 month, also take medication Seroquel, and have Depression . We study 60,730 people who have side effects while taking Wellbutrin from FDA. Among them, 88 have Neuroleptic malignant syndrome. Find out below who they are, when they have Neuroleptic malignant syndrome and more.

What to expect?

If you take Wellbutrin and have Neuroleptic malignant syndrome, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Wellbutrin and have Neuroleptic malignant syndrome

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

Wellbutrin

Wellbutrin has active ingredients of bupropion hydrochloride. It is often used in depression. (latest outcomes from Wellbutrin 70,871 users)

Neuroleptic Malignant Syndrome

Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents) has been reported by people with schizophrenia, depression, bipolar disorder, psychotic disorder, parkinson's disease (latest reports from 9,414 Neuroleptic malignant syndrome patients).

On Feb, 07, 2017

60,730 people reported to have side effects when taking Wellbutrin.
Among them, 88 people (0.14%) have Neuroleptic Malignant Syndrome


Number of reports submitted per year:

Could Wellbutrin cause Neuroleptic malignant syndrome?

Time on Wellbutrin when people have Neuroleptic Malignant Syndrome *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Neuroleptic Malignant Syndrome when taking Wellbutrin *:

  • female: 58.33 %
  • male: 41.67 %

Age of people who have Neuroleptic Malignant Syndrome when taking Wellbutrin *:

  • 0-1: 2.9 %
  • 2-9: 0.0 %
  • 10-19: 4.35 %
  • 20-29: 7.25 %
  • 30-39: 18.84 %
  • 40-49: 20.29 %
  • 50-59: 24.64 %
  • 60+: 21.74 %

Top conditions involved for these people *:

  • Depression (21 people, 23.86%)
  • Bipolar Disorder (15 people, 17.05%)
  • Schizophrenia (14 people, 15.91%)
  • Sleep Disorder (8 people, 9.09%)
  • Insomnia (6 people, 6.82%)

Top co-used drugs for these people *:

  • Seroquel (39 people, 44.32%)
  • Zyprexa (25 people, 28.41%)
  • Risperdal (24 people, 27.27%)
  • Lexapro (16 people, 18.18%)
  • Depakote (16 people, 18.18%)

Top other side effects for these people *:

  • Fever (15 people, 17.05%)
  • Diabetes (15 people, 17.05%)
  • Blood Creatine Phosphokinase Increased (13 people, 14.77%)
  • Type 2 Diabetes (12 people, 13.64%)
  • Muscle Rigidity (9 people, 10.23%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Neuroleptic malignant syndrome when taking Wellbutrin?

Browse all side effects of Wellbutrin

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Neuroleptic malignant syndrome

Neuroleptic malignant syndrome

Could your condition cause Neuroleptic malignant syndrome

Neuroleptic malignant syndrome

Related studies

Can you answer these questions?

More questions for: Wellbutrin, Neuroleptic malignant syndrome

You may be interested in these reviews

More reviews for: Wellbutrin, Neuroleptic malignant syndrome